INM logo

InMed Pharmaceuticals (INM) Company Overview

Profile

Full Name:

InMed Pharmaceuticals Inc.

Sector:

Healthcare

Country:

Canada

IPO:

May 5, 2014

Indexes:

Not included

Description:

InMed Pharmaceuticals is a biotechnology company focused on developing cannabinoid-based therapies. They aim to create innovative treatments for various medical conditions, including skin disorders and neurodegenerative diseases, by using their expertise in cannabinoids and drug development. Their goal is to improve patient health and quality of life.

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

Sep 30, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 15, 2024

Analyst ratings

Recent major analysts updates

Dec 22, 21 HC Wainwright & Co.
Buy
Nov 29, 21 HC Wainwright & Co.
Buy
Feb 16, 21 Roth Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for InMed Pharmaceuticals?
  • Does InMed Pharmaceuticals pay dividends?
  • What sector is InMed Pharmaceuticals in?
  • What industry is InMed Pharmaceuticals in?
  • What country is InMed Pharmaceuticals based in?
  • When did InMed Pharmaceuticals go public?
  • Is InMed Pharmaceuticals in the S&P 500?
  • Is InMed Pharmaceuticals in the NASDAQ 100?
  • Is InMed Pharmaceuticals in the Dow Jones?
  • When was InMed Pharmaceuticals's last earnings report?
  • When does InMed Pharmaceuticals report earnings?
  • Should I buy InMed Pharmaceuticals stock now?

What is the ticker symbol for InMed Pharmaceuticals?

The ticker symbol for InMed Pharmaceuticals is NASDAQ:INM

Does InMed Pharmaceuticals pay dividends?

No, InMed Pharmaceuticals does not pay dividends

What sector is InMed Pharmaceuticals in?

InMed Pharmaceuticals is in the Healthcare sector

What industry is InMed Pharmaceuticals in?

InMed Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is InMed Pharmaceuticals based in?

InMed Pharmaceuticals is headquartered in Canada

When did InMed Pharmaceuticals go public?

InMed Pharmaceuticals's initial public offering (IPO) was on May 5, 2014

Is InMed Pharmaceuticals in the S&P 500?

No, InMed Pharmaceuticals is not included in the S&P 500 index

Is InMed Pharmaceuticals in the NASDAQ 100?

No, InMed Pharmaceuticals is not included in the NASDAQ 100 index

Is InMed Pharmaceuticals in the Dow Jones?

No, InMed Pharmaceuticals is not included in the Dow Jones index

When was InMed Pharmaceuticals's last earnings report?

InMed Pharmaceuticals's most recent earnings report was on Feb 12, 2025

When does InMed Pharmaceuticals report earnings?

The next expected earnings date for InMed Pharmaceuticals is May 14, 2025

Should I buy InMed Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions